NEWS UPDATE on 2021 Story – A Massachusetts federal judge dismissed money laundering charges against Dr. Kingsley R. Chin, former CEO of SpineFrontier Inc., following compliance with settlement terms in a related DOJ civil case and due to the transparency of surgeon payments under the Physician Payment Sunshine Act.
The dismissal of the money laundering charges against Dr. Kingsley R. Chin and SpineFrontier Inc. has several implications for both parties moving forward:
- Legal Relief and Focus on Business:
- Chin: With the criminal charges dismissed, Dr. Chin can focus more on his professional endeavors without the overhang of legal proceedings related to this matter. His statement reflects a renewed focus on innovation in spine surgery.
- SpineFrontier: Similarly, the company can now concentrate on its business operations, innovation, and market expansion without the distraction of ongoing legal battles concerning these charges.
- Reputation Management:
- Chin: The dismissal might help in partially restoring or at least stabilizing his professional reputation, especially in the medical and business communities. However, public perception might still be influenced by the civil settlement and the history of allegations.
- SpineFrontier: The company’s reputation could see a positive shift with the resolution of these allegations, but it would need to actively manage its image to rebuild trust among stakeholders, including patients, investors, and medical professionals.
- Operational Strategy:
- Innovation and Growth: Dr. Chin’s statements suggest a continued or even intensified focus on developing new technologies and methodologies in spine surgery, emphasizing outpatient procedures and LESS (Less Exposure Spine Surgery) technologies. This could lead to new product lines or enhancements in existing offerings.
- Compliance and Governance: The experience might lead to more stringent internal policies regarding financial dealings, compliance with healthcare laws, and transparency in consultant relationships to avoid future legal entanglements.
- Financial Implications:
- The civil settlement terms, involving payments over a five-year contingency period, imply that SpineFrontier and Dr. Chin have financial obligations to meet. This could influence cash flow management, investment in R&D, or expansion plans, but with these terms agreed upon, they can better plan financially.
- Market Position and Partnerships:
- The resolution of these legal issues could make it easier for SpineFrontier to forge new partnerships, secure investments, or enter new markets where the previous allegations might have been a deterrent. However, they must continue to demonstrate ethical business practices to regain or maintain trust.
- Legal Risks:
- Although one set of charges has been dismissed, both Chin and SpineFrontier should remain vigilant. Other legal challenges could arise, especially if there are still ongoing or future investigations or lawsuits related to their operations or past practices.
- Public and Professional Perception:
- Moving forward, Dr. Chin and SpineFrontier will need to engage in consistent, transparent communication to reshape public and professional perception. This includes publishing clinical outcomes, engaging in educational outreach, and perhaps focusing on social responsibility or community health initiatives to improve their image.
In summary, while the dismissal of the money laundering charges provides a significant relief, Dr. Chin and SpineFrontier must navigate their future with careful attention to both their legal compliance and their public image, using this as an opportunity to reaffirm their commitment to innovation and ethical practices in the medical field
Read press release today – Dr. Kingsley R. Chin: Federal Judge Dismisses Money Laundering Charges in His Former Role as CEO of SpineFrontier Inc.
2021 – CEO, CFO and Boston-Area Spinal Device Company Charged in Bribery and Money Laundering Scheme (DOJ Massachusetts)
Defendants allegedly paid surgeons between $32,000 and $978,000 in bribes during the conspiracy
BOSTON – A spinal device manufacturer based in Malden, Mass. and its Chief Executive Officer (CEO) and Chief Financial Officer (CFO) were arrested today and charged in connection with a kickback scheme to bribe surgeons to use company products in exchange for sham consulting fees.
Kingsley R. Chin, MD, 57, of Fort Lauderdale, Fla., the CEO and founder of SpineFrontier; Aditya Humad, 36, of Cambridge, Mass., the company’s CFO; and SpineFrontier, Inc., were indicted on one count of conspiracy to violate the Anti-Kickback Statute, six counts of violations of the Anti-Kickback Statute and one count of conspiracy to commit money laundering.
According to the indictment, SpineFrontier, Chin and Humad paid, and conspired to pay, millions of dollars in bribes to surgeons in the form of sham consulting fees for work they did not perform. The defendants allegedly bribed surgeons to use SpineFrontier’s products, and in turn, SpineFrontier received millions of dollars in revenue from surgeries the surgeons performed.
The defendants allegedly entered into contracts with surgeons, agreeing to pay the surgeons between $250 and $1,000 per hour for purported consulting for SpineFrontier. In reality, however, the defendants allegedly paid the surgeons for using SpineFrontier’s products. Although the surgeon-consulting program was purportedly directed at gathering technical feedback about SpineFrontier’s products, the indictment alleges that Chin and Humad designed and used the program, and the bribes they paid pursuant to that program, to induce surgeons to use SpineFrontier’s products in surgeries that were paid for by federal health care programs such as Medicare, Medicaid, TRICARE and VHA. It is further alleged that the surgeons frequently spent only a small fraction of their reported time, if any at all, performing actual consulting. On numerous occasions the bribe amounts were determined following a review of the number of procedures a surgeon performed and the amount of revenue those procedures generated for SpineFrontier. The defendants allegedly paid each surgeon described in the indictment between $32,625 and $978,000 in bribes during the conspiracy.
“Kickback arrangements pollute federal health care programs and take advantage of patient needs for financial gains,” said Acting United States Attorney Nathaniel R. Mendell. “Medical device manufacturers must play by the rules and we will keep pursuing those who fail to do so, regardless of how their corruption is disguised.”
“Kickbacks paid to surgeons as sham medical consultants, as alleged in this case, cheat patients and taxpayers alike,” said Phillip M. Coyne, Special Agent in Charge of the U.S. Department of Health and Human Services, Office of Inspector General. “Working with our law enforcement partners, we will continue to investigate kickback schemes that threaten the integrity of our federal health care system, no matter how those schemes are disguised.”
“As alleged, Chin, Humad, and their medical device company SpineFrontier conspired to pay out millions of dollars in kickbacks in the form of sham consulting fees to surgeons across the country who sadly, prioritized these payoffs over their patients’ best interests. We believe they also cheated taxpayers who ultimately foot the bill for their medical procedures,” said Joseph R. Bonavolonta, Special Agent in Charge of the FBI Boston Division. “Today’s arrests show that the FBI will not hesitate to go after those who try to undermine the integrity of the medical decision-making process to take advantage of patients for their own personal gain.”
This indictment follows two guilty pleas in related criminal prosecutions. In August 2020, Jason Montone, D.O., 45, of Lawson, Miss., pleaded guilty to conspiracy to violate the Anti-Kickback Statute and obstruction and John Balzer, 43, of Lenexa, Kan., pleaded guilty to conspiracy to violate the Anti-Kickback Statute and one count of witness tampering. Montone and Balzer are scheduled to be sentenced on March 22 and 23, 2022, respectively.
The charge of conspiring to violate the Anti-Kickback Statute provides for a sentence of up to five years in prison, three years of supervised release, a fine of $250,000 or twice the gross gain or gross loss resulting from the offense, whichever is greater, forfeiture and restitution. The charges of violating the Anti-Kickback Statute provide for a sentence of up to 10 years in prison, three years of supervised release, a fine of up to $100,000, forfeiture and restitution. The charge of conspiracy to commit money laundering provides for a sentence of up to 20 years in prison, three years of supervised release, a fine of $500,000 or twice the value of the property involved in the transaction, whichever is greater, forfeiture and restitution. Sentences are imposed by a federal district court judge based upon the U.S. Sentencing Guidelines and other statutory factors.
Acting U.S. Attorney Mendell, HHS-OIG SAC Coyne and FBI SAC Bonavolonta made the announcement today. Valuable assistance was provided by the U.S. Department of Veterans Affairs, Office of Inspector General, Northeast Field Office and the U.S. Postal Service, Office of Inspector General. Assistant U.S. Attorneys Patrick M. Callahan, David J. Derusha, Abraham R. George and David G. Lazarus of Mendell’s Office are prosecuting the criminal case.
The details contained in the indictment are allegations. The defendants are presumed innocent unless and until proven guilty beyond a reasonable doubt in a court of law.